Other AnnouncementsResearch News Report from the CASTLE Patient Advisory Group Members of CASTLE's Southern advisory panel met this month for the first time. This meeting…ChildhoodEpilepsyAdminMarch 5, 2018
Research News CREME/ROLAND Study Update Percentage change of cortical thickness in healthy control (left) and two children with Rolandic epilepsy…ChildhoodEpilepsyAdminFebruary 26, 2018
Research News Visit the new CASTLE Study website! The brand new CASTLE project website is up and running! CASTLE stands for 'Changing Agendas…ChildhoodEpilepsyAdminFebruary 26, 2018
Research News BIOJUME Study Update It’s been a great start to the year for our BIOJUME study, with patients now…ChildhoodEpilepsyAdminFebruary 26, 2018
Other AnnouncementsResearch News Recruiting CASTLE Advisory Group Members Read more about CASTLE hereChildhoodEpilepsyAdminNovember 20, 2017
Other Announcements Valproate Class Action Suit, EMA report Sodium valproate, a common antiepileptic drug that has been in use since 1967 has been…ChildhoodEpilepsyAdminNovember 16, 2017
ConferencesResearch News REGAIN in Barcelona, Sept 2017 Barcelona hosted the 32nd International Epilepsy Congress this year and our team was well represented…ChildhoodEpilepsyAdminNovember 16, 2017
Other AnnouncementsResearch News DESIRE 4th Annual meeting, Valletta, October 2017 The 4th meeting of the DESIRE-FP7 European consortium took place in the beautiful city of…ChildhoodEpilepsyAdminNovember 16, 2017
Other AnnouncementsResearch News Update on BIOJUME Sites and Recruitment One of our lab’s current studies is the BIOJUME study, which aims to learn more…ChildhoodEpilepsyAdminNovember 13, 2017
Research News BIOJUME Study Featured in Epilepsy Professional Magazine Our Biology of JME (BIOJUME) study has been featured in Epilepsy Professional Magazine’s Summer 2017…ChildhoodEpilepsyAdminOctober 31, 2017